Skip to main content
    C

    Cardlytics Inc (CDLX)

    Official site

    COMMUNICATION SERVICES • ADVERTISING AGENCIES • NASDAQ

    $1.29
    -0.05 (-3.73%)

    Market Cap: $8.18M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    Cardlytics Inc (CDLX) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Cardlytics (CDLX) to earn -$2.69 per share in the fiscal year ending Dec 31, 2026, on revenue of $140.12M. Of 4 analysts, 0 rate the stock Buy or Strong Buy, 3 Hold and 1 Sell or Strong Sell, for a consensus of Sell. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$3.96.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 3.50, inside the Sell band from 3.5 up to 4.5. Sell and Strong Sell make up 25% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy00.0%
    Hold375.0%
    Sell00.0%
    Strong Sell125.0%
    Consensus
    Sell
    Total analysts
    4

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates rise 7.9%.

    Fiscal year ending Dec 31, 2026
    -$2.69
    EPS consensus, revenue $140.12M
    Fiscal year ending Dec 31, 2027
    -$3.96
    EPS consensus, revenue $151.25M
    Next report
    Mar 2, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$2.69-$4.05 to -$1.322$140.12M$139.60M to $141.08M3
    Dec 31, 2027-$3.96-$5.26 to -$2.652$151.25M$141.08M to $161.30M4

    Quarterly Estimates

    The EPS consensus falls from -$0.86 for the quarter ending Dec 31, 2026 to -$1.45 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.86-$1.14 to -$0.565$36.25M$34.79M to $37.36M5
    Mar 31, 2027-$1.45-$2.02 to -$0.872$32.08M$29.96M to $34.20M2

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202600
    Fiscal year ending Dec 31, 202710
    Quarter ending Mar 31, 202710

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$2.31.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$2.69-$2.31-$2.31-$2.31-$2.31N/A
    Fiscal year ending Dec 31, 2027-$3.96-$3.30-$3.30-$3.30-$3.30N/A
    Quarter ending Mar 31, 2027-$1.45-$1.39-$1.39-$1.39-$1.39N/A

    Frequently Asked Questions About CDLX

    What is the CDLX stock forecast?

    Consensus analyst estimates put Cardlytics's EPS at -$2.69 for the fiscal year ending Dec 31, 2026, on revenue of $140.12M. The consensus rating from 4 analysts is Sell.

    How do analysts rate CDLX stock?

    Of 4 analysts covering Cardlytics, 0 rate it Strong Buy, 0 Buy, 3 Hold, 0 Sell and 1 Strong Sell, for a consensus of Sell.

    What EPS do analysts expect from CDLX next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.69, with estimates from -$4.05 to -$1.32 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$3.96, with estimates from -$5.26 to -$2.65 from 2 analysts.

    What revenue do analysts expect from Cardlytics next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $140.12M, with estimates from $139.60M to $141.08M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $151.25M, with estimates from $141.08M to $161.30M.

    How many analysts cover CDLX?

    4 analysts rate Cardlytics stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.